Skip to main
ISRG
ISRG logo

Intuitive Surgical (ISRG) Stock Forecast & Price Target

Intuitive Surgical (ISRG) Analyst Ratings

Based on 13 analyst ratings
Buy
Strong Buy 23%
Buy 54%
Hold 15%
Sell 0%
Strong Sell 8%

Bulls say

Intuitive Surgical's positive outlook is underscored by a 14% increase in Ion utilization and a notable growth of 35% in SP system utilization, illustrating robust demand for the company's innovative surgical solutions. The increase in gross margin guidance to 67-67.5%, driven by higher US system placements and a favorable tariff outlook, further enhances the company's financial health. Additionally, the growth in Da Vinci utilization, supported by the efficiency benefits of the D5 system, indicates strong procedural adoption and positions the company for sustained revenue growth.

Bears say

Intuitive Surgical's recent financial performance exhibits several red flags contributing to a negative outlook for the company's stock. Revenue from services fell short of expectations at $396 million, coupled with pressures from macroeconomic uncertainty that are leading hospitals to restrain or defer robotic purchasing decisions. Additionally, challenges such as market resistance to robotic surgical approaches, longer-than-anticipated rollouts of new systems, and tariff impacts from manufacturing in Mexico further complicate Intuitive Surgical's growth trajectory and overall financial stability.

Intuitive Surgical (ISRG) has been analyzed by 13 analysts, with a consensus rating of Buy. 23% of analysts recommend a Strong Buy, 54% recommend Buy, 15% suggest Holding, 0% advise Selling, and 8% predict a Strong Sell.

This aggregate rating is based on analysts' research of Intuitive Surgical and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Intuitive Surgical (ISRG) Forecast

Analysts have given Intuitive Surgical (ISRG) a Buy based on their latest research and market trends.

According to 13 analysts, Intuitive Surgical (ISRG) has a Buy consensus rating as of Dec 10, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $590.15, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $590.15, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Intuitive Surgical (ISRG)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.